F2A

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameF2A
Drug Alias Namesynthetic FGF-2 mimetic (BioSET)synthetic FGF-2 mimetic (BioSurface Engineering Technologies)FibratideF2AF2A4-K-NS
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBone modulatorsAngiogenesis modulatorsFibroblast growth factor receptor 2 agonists
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsAngiogenesis disorderFractures, BoneWounds and Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiosurface Engineering Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosurface Engineering Technologies Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderFractures, BoneWounds and Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksN/A